RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

In a report released on January 17, Jon Arfstrom from RBC Capital maintained a Buy rating on Webster Financial (WBS – Research Report), with a ...

Morgan Stanley analyst Robert Koh maintained a Buy rating on AGL Energy Limited (AGLNF – Research Report) today and set a price target of ...

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...

Robinhood fined $65 million by SEC. Analysts bullish on company's growth potential in crypto industry under incoming Trump ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

Funding for Seven & i founding family buyout will be finalised by end Dec, say sources November 20, 2024 Activist investor Gatemore Capital on ... dealmaking in 2025 Morgan Stanley is looking ...

“We think Morgan Stanley benefits from favorable secular trends in the capital markets, wealth management, and investment banking,” he said in a research note. Morgan Stanley’s revenue from ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...

Research analysts at BMO Capital Markets began coverage on shares of Toast (NYSE:TOST – Get Free Report) in a report released ...